Fluoxetine versus amineptine in the treatment of outpatients with major depressive disorders.
Int Clin Psychopharmacol
; 4 Suppl 1: 97-101, 1989 Jan.
Article
en En
| MEDLINE
| ID: mdl-2644344
ABSTRACT
Fluoxetine, a selective serotonin reuptake inhibitor, was compared to amineptine, a tricyclic antidepressant agent, in the treatment of 63 outpatients with major depressive disorders of mild or moderate severity. Patients were randomly assigned to 6 weeks of treatment with either fluoxetine or amineptine. Fluoxetine was found to have a more marked therapeutic effect than that of amineptine better efficacy, fewer side-effects, and quicker and better improvement on the self evaluation scales.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Fluoxetina
/
Trastorno Depresivo
/
Dibenzocicloheptenos
Tipo de estudio:
Clinical_trials
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
1989
Tipo del documento:
Article